• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Zoom’s stock drop likely nixed Five9 deal, say analysts

October 1, 2021 by David Barret Leave a Comment

October 1, 2021

By Aniruddha Ghosh

(Reuters) – A slump in Zoom Video Communications Inc’s share price likely limited its ability to sweeten a nearly $15 billion all-stock offer for call center software firm Five9 and led to the deal’s collapse, Wall Street analysts said on Friday.

Five9 shareholders on Thursday voted down the sale to Zoom, denting the company’s efforts to diversify its offerings as growth slows in its virtual conferencing business after a boom during the pandemic.

While some analysts expected Zoom to raise its offer to address Five9 shareholder worries about the price, others said an almost 30% drop in Zoom shares since July on the back of slowing growth only dampened the prospects.

Under the deal terms, Five9 shareholders would have received 0.5533 Zoom share for each share held. The terms then implied a 12.8% premium over Five9’s market price.

“The deal was negatively perceived from the beginning given the small premium and all-stock structure,” Jefferies analyst Samad Samana said in a note to clients. “ZM’s stock declining 28% since the announcement only compounded the issues and likely made revising the terms difficult as well.”

The deal – which would have been Zoom’s biggest-ever purchase if completed – was also opposed by shareholder proxy advisory firms ISS and Glass Lewis. The firms had recommended that Five9 shareholders vote against the deal, citing growth concerns and dual-class shares.

“While we think the deal made strategic sense for both companies over the long term, the variable deal tied to volatile (Zoom) shares was not an economically attractive deal for (Five9) shareholders at this time,” Piper Sandler analysts said.

Analysts at Barclays blamed the fall in Zoom’s share price and possible regulatory scrutiny for the deal falling through.

A U.S. Justice Department panel had been reviewing the deal over possible national security concerns, though analysts had said it was unlikely the deal would be scrapped as a result.

“(Our) conversations, especially with event-driven investors, suggest that they believe Five9 was important enough to Zoom that they would ultimately bump/sweeten the offer for Five9,” J.P. Morgan analysts said.

“Obviously, the recent pullback in stock prices for premium valuation software stocks makes the current situation all the more complicated.”

Zoom’s shares gained 1.6% to $265.79 in premarket trading, while Five9’s stock was down about 3% at $155.

(Reporting by Aniruddha Ghosh in Bengaluru; Editing by Sachin Ravikumar and Sriraj Kalluvila)

Source Link Zoom’s stock drop likely nixed Five9 deal, say analysts

David Barret
David Barret

Related posts:

  1. Australia central bank to stick with tapering plans, or maybe not
  2. Japan firms see economy recovering to pre-COVID level in FY2022
  3. Air New Zealand studying how to add low-emissions planes to fleet
  4. ECB’s Lagarde flags bottlenecks, energy and virus as key risks

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • There’s A Very Intriguing Reason Why Great White Sharks Have White Bellies
  • NASA’s Space Probe Finds Evidence Of A “Helicity Barrier” In The Sun’s 2 Million Kelvin Atmosphere
  • Why Do Some People Talk In Their Sleep?
  • Can Animals Think? Understanding Them Could Be Key To Communicating With Aliens One Day
  • The World’s Only White Giraffe Has A Tragic Story
  • Are You More Likely To Be Killed By An Elephant Or An Asteroid? RFK Jr Pulls Millions Of Dollars Of mRNA Vaccine Funding, And Much More This Week
  • ChatGPT Poisoned A Guy Into Psychosis, Case Study Shows
  • 8 Key DNA Regions More Likely To Be Altered In People With ME/CFS, Finds 27,000-Strong Study
  • Quantum “Schrödinger’s Cat” Survives For Mind-Blowing 23 Minutes In Record-Breaking Experiment
  • World-First Estimate Shows Over 13 Million Babies Born Through Assisted Reproduction
  • Californian Wild Pigs Found With Bright Blue Flesh, Officials Warn Public To “Be Aware”
  • Dancing Cockatoos, Spider Schlongs, And Will I Be Hit By An Asteroid?
  • NASA Releases Closest Ever Images Of The Sun, Snapped As Probe Travels Through Its Atmosphere
  • Grizzly Adams: The Wild Truth Behind The Man, The Myth, And The Beard
  • Sergei Krikalev: A Cosmonaut Left Stranded In Space When The Soviet Union Collapsed
  • “We Have No Idea”: Decades-Old Mystery About Great White Sharks Just Got Even Stranger
  • Sharks Don’t Have Bones To Fossilize, So How Do We Know Megalodon’s Size?
  • The Year’s Best Meteor Shower Is About To Hit Its Peak – How To Bag Yourself A “Fireball”
  • “Smoking Gun” Causing Parts Of Antarctic Ocean To Shine Weirdly Bright In Satellite Images Discovered
  • Watch: Endangered Foa’s Red Colobus Monkey Caught On Film For The First Time
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version